Start with the awkward finding, because it changes what this page is for. Limited research suggests that use of psychedelic drugs such as psilocybin and LSD does not typically lead to addiction [1]. Researchers think one reason is that people often get unpleasant side effects, including headaches and nausea, which reduces the desire to take them again [1].
That is not the same as “no reason to seek help”. A diagnosis does exist. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders includes “other hallucinogen use disorder” [1]. Federal survey data put 0.2% of people aged 12 or older, about 493,000 people, as having a hallucinogen use disorder in the past 12 months in 2020 [1]. This page covers what treatment is actually for here, how it is chosen, and what it costs. Our page on LSD abuse covers the drug itself.
When LSD Use Becomes Something Treatment Can Help With
Four situations bring people to an assessment, and only one of them is what most people picture.
The first is tolerance and escalation. Federal summaries note that some evidence suggests people may quickly develop a tolerance to psychedelic drugs, meaning they need more of the drug for the same effects [1]. Escalation without a physical dependence is still a pattern worth looking at.
The second is polysubstance use, and it is the most common. LSD rarely arrives alone. What treatment is often addressing is the alcohol, stimulants or benzodiazepines around it.
The third is mental health. Federal summaries record that people who use these substances report strong emotions, ranging from intense happiness and connectedness to fear, anxiety and confusion [1]. Where the fear and confusion persist afterwards, that is a clinical matter.
The fourth is consequence. Use that continues despite harm is the actual definition, and it does not require withdrawal to qualify. Our page on hallucinogens covers the class as a whole.
Assessment: What a Clinician Looks For Before Recommending a Level of Care
The assessment is the appointment that sets the level of care. Nothing is chosen off a list.
For this drug the questions tilt in a particular direction. What else is being used, and how much. What the mental state has been like between episodes, not only during them. Whether perceptual disturbances have carried on afterwards. Whether there is a personal or family history of psychosis or bipolar disorder, which changes risk. And what support exists at home.
Federal research guidance asks for a plan built around the person. It should address their own drug use patterns together with their drug-related medical, mental and social problems [2]. On an LSD page that instruction does most of the work, because the drug is frequently not the main problem.
Our rehab process page explains where the assessment sits, and our levels of care guide describes what it chooses between.
Does LSD Need Medical Detox First?
Generally no, and pretending otherwise would be selling a level of care nobody needs.
Federal summaries describe physical side effects of psychedelic and dissociative drugs, such as headache, nausea or changes in heart rate, as generally not life-threatening [1]. The same summaries attach a caveat to that sentence, and on a drug sold only in unregulated form it is the part to read twice: illicitly manufactured or processed drugs may be contaminated with colorless and odorless fentanyl or other dangerous substances that can cause serious adverse events, including overdose and death [1]. There is no recognized physical withdrawal syndrome for LSD in the way there is for alcohol or opioids. Federal research summaries are still working out how often and to what extent tolerance, withdrawal and other symptoms occur across this class [1].
Detox becomes relevant when something else is in the picture. Alcohol and benzodiazepines are the two that make withdrawal a medical procedure rather than a discomfort. Where either is present, the setting changes, and federal guidance sets out those settings from a physician’s office through freestanding programs and partial hospitalization to acute care inpatient units, mapped onto the five adult detox levels used by the American Society of Addiction Medicine [3].
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental health crisis, call or text 988.
Where detox does happen, it is an opening rather than a treatment. Federal guidance states that detoxification is not substance abuse treatment and rehabilitation [4]. Our medical detox page covers the level of care and our withdrawal symptoms page compares classes.
Assessment and treatment in Florida
Our campus at Umatilla, Florida, in Lake County northwest of Orlando, is The Recovery Village Umatilla. Medical detox, residential and inpatient care, inpatient rehab for mental health, a partial hospitalization program, outpatient care and aftercare planning all run from that one site. Booking the assessment is the useful first move, and benefits can be checked in the same conversation.
See treatment options in Florida
Verify your insurance
The Recovery Village Umatilla is part of our family of treatment centers. See the Recovery Village Umatilla campus.
Residential Treatment for LSD Use, and Who It Suits
Residential care is not usually recommended for LSD use on its own. It is recommended for what tends to sit next to it.
Three situations make it the right call. A co-occurring mental health condition that needs daily clinical contact. Another substance in the picture whose withdrawal needs managing. Or a home environment where the use is woven into daily life and cannot be interrupted any other way.
If none of those applies, a residential bed is the wrong tool. Being told that plainly is more useful than being admitted to a level of care that does not fit. Our inpatient rehab page describes what living at a program involves, and how long rehab takes covers the overall arc.
PHP and IOP for LSD Use
These two levels carry most of the treatment that happens here, and for good reason.
A partial hospitalization program fills most of a clinical day. The person sleeps elsewhere. An intensive outpatient program is lighter, usually a few hours several days a week, built around work or study.
Both suit this situation better than a bed does. The work is largely psychological and social rather than medical. It is about the context the use sits in, the other substances, and the mental state underneath. All of that can be addressed while somebody continues an ordinary week, and doing it in the ordinary week is often the point.
Our outpatient rehab page sets out how those schedules are built.
Therapies With the Strongest Evidence for This Substance
There is no medication for this, so the therapy is not an addition to the treatment. It is the treatment.
Federal research guidance describes cognitive behavioral therapy as work that “seeks to help patients recognize, avoid, and cope with the situations in which they’re most likely to use drugs” [2]. It describes contingency management as using positive reinforcement, such as rewards or privileges, for remaining drug free and for attending and participating in counseling sessions [2]. It also notes that behavioral therapies help people stay in treatment longer [2].
For LSD specifically, two things are worth asking a program about. Whether it treats co-occurring anxiety and mood conditions in-house, since those are often the real target. And whether it has experience with persistent perceptual symptoms, which are a recognized problem and not a moral failing.
Our pages on substance abuse counseling techniques and on what CBT is describe those sessions.
Medication Options, Where They Exist
No medication is approved to treat LSD use, and the honest version of that sentence has two halves.
Federal research guidance sets out which drug classes have medications behind them. Opioids, nicotine and alcohol do [2]. This class does not. Where no medication exists for a class, federal guidance says treatment consists of behavioral therapies [2].
The second half matters more here than on most pages. What often does get treated with medication is the anxiety, the low mood or the sleep problem sitting alongside, and for some people that is the whole reason treatment works. Where another substance is also in use, medication-assisted treatment may apply to that.
Separately, psychedelic compounds are being studied as medications under supervision. That is a different question from treating someone’s use of them, and the two get confused constantly. No amounts or schedules appear on this page.
Co-occurring Mental Health Conditions and Why They Change the Plan
On this page this section is not an add-on. It is usually the main event.
Federal summaries record the emotional range people report with these drugs, from intense happiness and connectedness to fear, anxiety and confusion [1]. Where the difficult end persists between episodes of use, it is a condition to treat rather than an after-effect to wait out.
Two consequences follow. First, say what the mental state has been like on the assessment call, including anything frightening. Second, expect the recommendation to change if the answer is significant, usually toward a level of care with daily clinical contact and a psychiatrist attached.
Federal research guidance asks that the plan address the person’s mental and social problems alongside the drug use [2]. Our page on co-occurring conditions explains how both are treated together.
Paying for LSD Treatment and Verifying Benefits
The policy decides this, not the drug, and a benefits check is how you find out what yours says.
There is a federal floor under the answer, and a limit on who stands on it. Under parity rules, a plan that covers mental health and substance use benefits cannot subject them to financial requirements or treatment limits tougher than the predominant ones it uses on substantially all medical and surgical benefits in the same classification [5]. The people covered are those in non-federal governmental plans with more than 50 employees, those in private employer group plans of the same size, and those who buy their own coverage in the individual market [5]. Everyone in a small-employer group plan is outside that. They are not left with nothing: non-grandfathered small-group and individual plans have to include this care as an essential health benefit under the Affordable Care Act [5], and anything bought on the Marketplace carries no yearly or lifetime dollar ceiling on it [6].
Two numbers give the shape of the bill. This site’s what rehab costs page publishes $350 to $450 a day for partial hospitalization, and $3,000 to $10,000 for thirty days of intensive outpatient care. They are our own ranges and not federal figures, and they are not a quote for your case. Read our insurance coverage guide before the call, how to get into rehab for what happens after it, and our nationwide directory of rehab facilities for where we run.
Frequently Asked Questions
Do I need inpatient treatment for LSD use? Usually not for LSD alone. Federal summaries say limited research suggests psychedelic drugs such as LSD do not typically lead to addiction. A bed becomes the right answer when something else is present: another substance whose withdrawal needs managing, a mental health condition needing daily contact, or a home situation that cannot be interrupted otherwise.
Is there a medication for LSD addiction? No. Federal research guidance sets out which drug classes have a medication behind them, and this is not one of them; where a class has none, treatment consists of behavioral therapies. What can be prescribed for is what sits alongside, such as anxiety, low mood or a sleep problem, and that is often what makes the difference.
How long does LSD treatment take? Think in months. The federal research guidance most often quoted says most people with an addiction need three months or more before use drops significantly, and that longer courses do better. What counts is total time under care, adding up every level a person passes through. Where a mental health condition is being treated too, that total usually grows.
Will insurance cover it? In most cases partly, and the policy document is what settles it. Where a plan includes this care, parity rules forbid tougher financial requirements or limits than the predominant ones covering substantially all its medical and surgical benefits. Marketplace policies come with no yearly or lifetime dollar ceiling on it. Nothing beats having admissions run the check.
What happens on the first call? It is a screening, held in confidence, and it commits you to nothing. Expect to be asked about the substance and the pattern, about anything else in use, about earlier attempts at treatment, about prescriptions and diagnoses, and about who is around at home. Coverage is often checked during the same conversation. The clinical assessment is a separate step and it is the one that sets the level of care.
Sources
- National Institute on Drug Abuse. Psychedelic and Dissociative Drugs. National Institutes of Health. https://nida.nih.gov/research-topics/psychedelic-dissociative-drugs
- National Institute on Drug Abuse. Drugs, Brains, and Behavior: The Science of Addiction — Treatment and Recovery. National Institutes of Health. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 2: Settings, Levels of Care, and Patient Placement. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64109/
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 1: Overview, Essential Concepts, and Definitions in Detoxification. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64119/
- Centers for Medicare and Medicaid Services. The Mental Health Parity and Addiction Equity Act (MHPAEA). https://www.cms.gov/marketplace/private-health-insurance/mental-health-parity-addiction-equity
- HealthCare.gov. Mental Health and Substance Abuse Health Coverage Options. Centers for Medicare and Medicaid Services. https://www.healthcare.gov/coverage/mental-health-substance-abuse-coverage/
- National Institute on Drug Abuse. (2012). Principles of Drug Addiction Treatment: A Research-Based Guide, 3rd edition. National Institutes of Health. https://nida.nih.gov/sites/default/files/podat-3rdEd-508.pdf
This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.
Author
Chief Medical Officer,
The Recovery Village
